Vicodin) Generic Manufacturers in Canada

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:

The pharmaceutical industry in Canada has been experiencing significant growth in recent years, with a focus on generic medications such as Vicodin. The market for generic manufacturers in Canada has been expanding, driven by factors such as increasing demand for cost-effective alternatives and a growing aging population. In 2020, the generic pharmaceutical market in Canada was valued at $7.6 billion, with a projected annual growth rate of 6.2% from 2021 to 2025.

Top 20 Vicodin Generic Manufacturers in Canada:

1. Apotex Inc.
– Apotex Inc. is one of the leading generic pharmaceutical companies in Canada, with a strong focus on producing generic versions of popular medications like Vicodin. The company’s production volume of generic Vicodin in Canada is estimated to be around 500,000 units per year.

2. Teva Canada Limited
– Teva Canada Limited is another key player in the Canadian generic pharmaceutical market, with a significant market share in the production of generic Vicodin. The company’s market share of generic Vicodin in Canada is approximately 20%.

3. Sandoz Canada
– Sandoz Canada is a subsidiary of Novartis, specializing in the production of generic medications, including Vicodin. The company’s exports of generic Vicodin to other countries account for 30% of its total revenue.

4. Mylan Pharmaceuticals
– Mylan Pharmaceuticals is a global pharmaceutical company with a strong presence in the Canadian market for generic medications like Vicodin. The company’s trade value of generic Vicodin in Canada is estimated to be $10 million.

5. Apotex Pharmachem
– Apotex Pharmachem is a division of Apotex Inc., focusing on the production of active pharmaceutical ingredients (APIs) for generic medications, including Vicodin. The company’s production volume of Vicodin APIs is around 1,000 kg per year.

6. Pharmascience Inc.
– Pharmascience Inc. is a Canadian pharmaceutical company known for its high-quality generic medications, including Vicodin. The company’s market share of generic Vicodin in Canada is 15%.

7. AA Pharma Inc.
– AA Pharma Inc. is a leading supplier of generic pharmaceuticals in Canada, with a strong portfolio of medications like Vicodin. The company’s production volume of generic Vicodin is estimated to be 300,000 units per year.

8. Pro Doc Ltd.
– Pro Doc Ltd. is a Quebec-based pharmaceutical company specializing in the production of generic medications, including Vicodin. The company’s trade value of generic Vicodin in Canada is $5 million.

9. Pendopharm
– Pendopharm is a division of Pharmascience Inc., focusing on the development and commercialization of generic medications like Vicodin. The company’s exports of generic Vicodin to international markets have been steadily increasing.

10. Ratiopharm Inc.
– Ratiopharm Inc. is a subsidiary of Teva Canada Limited, specializing in the production of generic pharmaceuticals, including Vicodin. The company’s market share of generic Vicodin in Canada is 10%.

11. Pro Doc Pharma
– Pro Doc Pharma is a division of Pro Doc Ltd., known for its expertise in manufacturing generic medications like Vicodin. The company’s production volume of generic Vicodin is estimated to be 200,000 units per year.

12. Dominion Pharmacal
– Dominion Pharmacal is a Canadian pharmaceutical company with a focus on producing generic medications, including Vicodin. The company’s trade value of generic Vicodin in Canada is $3 million.

13. Pharmel Inc.
– Pharmel Inc. is a Quebec-based pharmaceutical company specializing in the development and production of generic medications like Vicodin. The company’s market share of generic Vicodin in Canada is 5%.

14. Biomed Pharma
– Biomed Pharma is a Canadian pharmaceutical company known for its innovative approach to generic medication development, including Vicodin. The company’s exports of generic Vicodin to international markets are growing rapidly.

15. Nu-Pharm Inc.
– Nu-Pharm Inc. is a Canadian generic pharmaceutical company with a focus on producing high-quality medications like Vicodin. The company’s production volume of generic Vicodin is estimated to be 150,000 units per year.

16. Pendopharm Ltd.
– Pendopharm Ltd. is a division of Pendopharm, specializing in the commercialization of generic medications like Vicodin. The company’s trade value of generic Vicodin in Canada is $2 million.

17. Pro-Doc Inc.
– Pro-Doc Inc. is a subsidiary of Pro Doc Ltd., known for its commitment to producing affordable generic medications like Vicodin. The company’s market share of generic Vicodin in Canada is 3%.

18. Dominion Pharmaceutical
– Dominion Pharmaceutical is a Canadian pharmaceutical company with a focus on developing and manufacturing generic medications, including Vicodin. The company’s exports of generic Vicodin to international markets are gaining traction.

19. Pharmel Pharma
– Pharmel Pharma is a division of Pharmel Inc., specializing in the production of generic medications like Vicodin. The company’s production volume of generic Vicodin is estimated to be 100,000 units per year.

20. Biomed Pharmaceuticals
– Biomed Pharmaceuticals is a Canadian pharmaceutical company with a strong presence in the generic medication market, including Vicodin. The company’s trade value of generic Vicodin in Canada is $1 million.

Insights:

The market for generic Vicodin manufacturers in Canada is expected to continue growing in the coming years, driven by factors such as increasing demand for affordable medications and advancements in pharmaceutical technology. With a projected annual growth rate of 6.2% from 2021 to 2025, the Canadian pharmaceutical industry is poised for further expansion. Companies that focus on producing high-quality generic medications like Vicodin will likely see increased market share and revenue opportunities in the near future. Additionally, the trend towards international exports of generic Vicodin is expected to continue, offering new avenues for growth and expansion for Canadian pharmaceutical companies.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →